Schedule I drug

In 2000, the FDA classified GHB as a Schedule I controlled substance. Punishment for possession, sale, or use of GHB became as severe as for other Schedule I drugs, including up to 20 years in prison. However, GHB was also subclassified as a Schedule III controlled substance, allowing for its medical use in patients with narcolepsy (see box on page 50). 

GHB has met a somewhat different fate in the United States, however. In 1990, the FDA banned the sale of the drug in the United States because of its concerns over possible risks to human health. In view of the generally positive research on the drug s use, the sci-entihc basis of the FDA s decision was not entirely clear at the time to some observers. In any case, the drug s legal status was clarified in 2000 when the DEA classihed it as a Schedule I drug under the Controlled Substances Act. 

Heroin is a Schedule I drug morphine, codeine, fentanyl, hydrocodone, hydromorphone, and oxycodone are Schedule II drugs codeine plus aspirin or acetaminophen is Schedule III propoxyphene is Schedule IV and codeine sold over the counter is Schedule V. 

Schedule I drugs such as heroin and LSD have no medical use. 

Schedule I drugs were subject to the greatest level of control and most severe punishment for illegal possession and Schedule V drugs the least level of control and mildest punishment. 

EXTENSIONS AND COMMENTARY In the 1960 s there was quite a bit of interest in a couple of pharmaceutical houses with the indole analogues of amphetamine. Both the alpha-methylated tryptamine (this compound, a-MT) and the alpha-ethylated homologue (a-ET, see its separate recipe) were found to be effective monoamine oxidase inhibitors, and both were clinically studied as potential antidepressants. The ethyl compound became a commercial drug, offered by the Upjohn Company as Monase, but now is considered to be without medical use and is a Schedule I drug. It is interesting that this methyl compound, a-MT was also a medically available antidepressant in the Soviet Union in the 1960 s and was sold under the name of Indopan, in 5 and 10 milligram tablets. 

C.R. Wright first synthesized heroin, or 3,6-diacetylmorphine, from morphine in 1874. The Bayer Company of Germany advertised heroin as an antitussive in 1898. Under U.S. law (but not the laws of many other countries) heroin has no accepted medical use it is classified as a Schedule I drug under the Controlled Substances Act of 1970. 

Manufacture of LSD becomes illegal in the United States. A year later is made illegal in the United Kingdom. The FDA subsequently classifies LSD as a Schedule I drug in 1970. 

GHB, a fast-acting central nervous system depressant, is made a Schedule I drug. In accord with the Controlled Substances Act (CSA), GHB is declared illegal in United States. 

DMT was demonstrated to be hallucinogenic in 1956. The drug is explicitly named as a Schedule I drug in the federal Controlled Substances Act. DMT is also illegal in the United Kingdom, where it is classified as a Class A drug. 

Schedule I drugs are illegal to possess, except in research performed under highly regulated conditions designed to protect patients. Other Schedule I drugs include heroin, marijuana, and LSD. 

In the United States, there is no legal use for LSD. As a Schedule I drug, it is considered by the U. S. government to have a high abuse potential, no known medical application, and questionable safety. 

The answer, according to the court, is no, since the Controlled Substance Act defines Schedule I drugs as those with no currently accepted medical use in treatment in the United States. The ruling allows state laws permitting the personal use and cultivation of medical marijuana to stand, but prohibits the kind of organized distribution that the cooperatives had engaged in, since, the court reasoned, these organizations cannot claim a medical necessity for marijuana use. 

Marijuana is a Schedule I drug under the Controlled Substances Act whose possession and distribution is for-... 

Methaqualone use and abuse in the United States dropped significantly after its reclassification to an illicit Schedule I drug. Fatalities and injuries related to the drug s use have also declined accordingly. According to the National Narcotics Intelligence Consumers Committee, annual U.S. emergency room visits related to methaqualone fell from 2,764 in 1982 to just 163 in 1988. 

The drug has only been illegal since 1995, when it was classified as a Schedule I drug under the CSA. 

---